Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Reduction of Proteinuria in IgA Nephropathy. Show all posts
Showing posts with label Reduction of Proteinuria in IgA Nephropathy. Show all posts
Wednesday, February 7, 2024

FDA Grants Accelerated Approval to Filspari (sparsentan) for the Reduction of Proteinuria in IgA Nephropathy

›
Travere Therapeutics, Inc. (Nasdaq: TVTX) announced  the U.S. Food and Drug Administration (FDA)  approval to  Filspari ™ (sparsentan) to re...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.